Omega Healthcare Investors (NYSE:OHI) Issues FY 2024 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 2.840-2.860 for the period, compared to the consensus EPS estimate of 2.830. The company issued revenue guidance of -.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on OHI. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. Truist Financial boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research report on Wednesday, September 4th. Mizuho cut shares of Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and boosted their price target for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th. Finally, Scotiabank boosted their price target on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “sector perform” rating in a research report on Monday, August 26th. Eight research analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $37.80.

Omega Healthcare Investors Trading Up 1.6 %

NYSE OHI traded up $0.68 on Wednesday, hitting $42.56. 1,681,560 shares of the stock were exchanged, compared to its average volume of 1,642,659. The company has a debt-to-equity ratio of 1.19, a quick ratio of 5.79 and a current ratio of 5.79. The stock has a fifty day moving average price of $40.25 and a two-hundred day moving average price of $35.79. The firm has a market capitalization of $10.97 billion, a P/E ratio of 31.97, a P/E/G ratio of 1.34 and a beta of 1.00. Omega Healthcare Investors has a 52-week low of $27.53 and a 52-week high of $42.67.

Omega Healthcare Investors (NYSE:OHI) last posted its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 EPS for the quarter, missing the consensus estimate of $0.65 by ($0.20). The firm had revenue of $252.70 million for the quarter, compared to analysts’ expectations of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm’s quarterly revenue was up 17.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.74 earnings per share. Research analysts forecast that Omega Healthcare Investors will post 2.69 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.30%. The ex-dividend date of this dividend is Monday, November 4th. Omega Healthcare Investors’s dividend payout ratio is currently 204.58%.

Insider Activity

In other news, COO Daniel J. Booth sold 56,725 shares of the business’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the transaction, the chief operating officer now owns 100,000 shares in the company, valued at approximately $4,025,000. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.